Genetic Analysis for the Diagnosis of Disorders of Sexual Development in Indonesia

*Sultana MH Faradz -  Faculty of Medicine Diponegoro University, Indonesia
Received: 15 Aug 2016; Published: 29 Dec 2016.
Open Access
Citation Format:
Article Info
Section: Short Communication
Language: EN
Full Text:
Statistics: 242 172
Abstract

Disorders of sex development (DSD) is defined by congenital conditions in which development of chromosomal, gonadal, or anatomical sex is atypical, while in clinical practice this term means any abnormality of the external genitalia. DSD patients have been managed by a multidisciplinary gender team in our center as collaboration between Dr. Kariadi province referral hospital and Faculty of Medicine Diponegoro University. Diagnosis should be established by specific physical examination hormonal, chromosomal and DNA studies; and imaging for most of the cases depending on indication.

Since 2004 the involvement of molecular and cytogenetic analysis so far can diagnosed many of the DSD cases. Most of the genetically proven cases were Congenital Adrenal hyperplasia, Androgen Insensitivity syndrome and sex chromosomal DSD that lead abnormal gonadal development.  Many of them remain undiagnosed, further testing such as advanced DNA study should be carried out in collaboration with other center in overseas.

The novel genes were found in some cases that contributed for the management of DSD.  Information for medical professionals, patients, family members and community about the availability and necessity of DSD diagnosis should be delivered to improve DSD management and patient quality of life.

Article Metrics:

  1. Hughes I A, Houk C, Ahmed S F, Lee P A and LWPES/ESPE (2006). Consensus Group disorders Consensus statement on management of intersex. Arch. Dis. Child,91;554-563
  2. Hughes IA, Nihoul-Fékété C, Thomas B, Cohen-KettenisPT(2007). Consequences of the conference on human genetics. J Genet Couns. Dec;22(6):917-24
  3. Pleskacova J, Hersmus R, Oosterhuis JW, Setyawati BA, Faradz SM, Cools M, Wolffenbuttel KP, Lebl J, Drop SL, Looijenga LH (2010). Tumor risk in disorders of sex development. Sex Dev. Sep,4(4-5):259-69 ESPE/LWPES guidelines for diagnosis and treatment of disorders of sex development. Best Pract Res ClinEndocrinolMetab, 21(3):351-65.
  4. Juniarto AZ, van der Zwan YG, Santosa A, Hersmus R, de Jong FH, Olmer R, et al. (2012) Application of the new classification on patients with a disorder of sex development in indonesia. International journal of endocrinology. 2012:237084.
  5. Juniarto, A.Z., van der Zwan, Y.G., Santosa, A., Ariani, M.D., Eggers, S., Hersmus, R., Themmen, A.P., Bruggenwirth, H.T., Wolffenbuttel, K.P., Sinclair, A., White, S.J., Looijenga, L.H., de Jong, F.H., Faradz, S.M., Drop, S.L. (2016) Hormonal evaluation in relation to phenotype and genotype in 286 patients with a disorder of sex development from Indonesia. Clinical Endocrinology, 1-11
  6. Eggers S, Smith KR, Bahlo M, Looijenga LHJ, Drop SLS, Harley VR, Koopman P, Faradz SMH, Sinclair AH (2014). Whole exome sequencing combined with linkage analysis identifies a novel deletion in NR5A1 in a family with 46,XY disorders of sex development and 46,XX premature ovarian insufficiency. Eur J Hum Genet. 23(4):486-93.
  7. Warne GL, Raza J. (2008). Disorders of sex development (DSDs), their presentation and management in different cultures. Rev Endocr Metab Disord. Sep;9(3):227-36.
  8. Zayts O, Sarangi S, Thong MK, Chung BH, Lo IF, Kan AS, Lee JM, Padilla CD, Cutiongco-de la Paz EM, Faradz SM, Wasant P (2013). Genetic counseling/consultation in South-East Asia: a report from the workshop at the 10th Asia pacific conference on human genetics. J Genet Couns. Dec;22(6):917-24
  9. Pleskacova J, Hersmus R, Oosterhuis JW, Setyawati BA, Faradz SM, Cools M, Wolffenbuttel KP, Lebl J, Drop SL, Looijenga LH (2010). Tumor risk in disorders of sex development. Sex Dev. Sep,4(4-5):259-69